Antioxidant Therapy Alters Brain MAPK-JNK and BDNF Signaling Path-ways in Experimental Diabetes Mellitus.
Réus, Gislaine Zilli
Antioxidant Therapy Alters Brain MAPK-JNK and BDNF Signaling Path-ways in Experimental Diabetes Mellitus. [electronic resource] - Current neurovascular research 2016 - 107-14 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1875-5739
10.2174/1567202613666160219115832 doi
Acetylcysteine--pharmacology
Analysis of Variance
Animals
Antioxidants--pharmacology
Brain--drug effects
Brain-Derived Neurotrophic Factor--metabolism
Deferoxamine--pharmacology
Diabetes Mellitus, Experimental--drug therapy
MAP Kinase Kinase 4--metabolism
Rats
Rats, Wistar
Signal Transduction--drug effects
p38 Mitogen-Activated Protein Kinases--metabolism
Antioxidant Therapy Alters Brain MAPK-JNK and BDNF Signaling Path-ways in Experimental Diabetes Mellitus. [electronic resource] - Current neurovascular research 2016 - 107-14 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1875-5739
10.2174/1567202613666160219115832 doi
Acetylcysteine--pharmacology
Analysis of Variance
Animals
Antioxidants--pharmacology
Brain--drug effects
Brain-Derived Neurotrophic Factor--metabolism
Deferoxamine--pharmacology
Diabetes Mellitus, Experimental--drug therapy
MAP Kinase Kinase 4--metabolism
Rats
Rats, Wistar
Signal Transduction--drug effects
p38 Mitogen-Activated Protein Kinases--metabolism